title: Effects of MCI-186 (edaravone), a novel free radical scavenger, upon experimental atherosclerosis in apolipoprotein E-deficient mice.
abstract: BACKGROUND
  Recent evidence suggests that oxidative stress may play a role in the development of atherosclerosis. MCI-186 (3-methyl-1-phenyl-1-phyrazolin-5-one, edaravone) is a novel free radical scavenger, but it remains unclear whether free radical scavengers would be effective for the prevention of the disease.
  
  
  RESULTS
  Experimental atherosclerosis was induced in apolipoprotein E-deficient mice fed a high-fat diet containing 0.3% cholesterol. Mice were treated with an intraperitoneal injection of either MCI-186 1 mg/kg per day or MCI-186 10 mg/kg per day on alternate days over 4 weeks. Fatty streak lesion was suppressed by MCI-186 10 mg/kg per day administration, but not by mg/kg per day. Immunohistochemical analysis showed that macrophage and CD4+ T-cell accumulation and oxidative stress overload in the fatty streak lesion were suppressed in mice that received MCI-186 treatment.
  
  
  CONCLUSIONS
  MCI-186 administration suppressed the development of atherosclerosis, associated with reduced expression of both immune-activated cells and oxidative stress in fatty streak plaques.
authors.affiliation: Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Japan.
authors.forename: Taka-aki
authors.initials: TA
authors.lastname: Okabe
authors.forename: Chiharu
authors.initials: C
authors.lastname: Kishimoto
authors.forename: Kana
authors.initials: K
authors.lastname: Shimada
authors.forename: Toshinori
authors.initials: T
authors.lastname: Murayama
authors.forename: Masayuki
authors.initials: M
authors.lastname: Yokode
authors.forename: Toru
authors.initials: T
authors.lastname: Kita
mesh_terms: D000818:Animals; D000983:Antipyrine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D001057:Apolipoproteins E / Q000172:deficiency*; D050197:Atherosclerosis / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology / Q000473:pathology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000473:pathology; D000077553:Edaravone; D016166:Free Radical Scavengers / Q000008:administration & dosage*; D051379:Mice; D018345:Mice, Knockout; D018384:Oxidative Stress / Q000187:drug effects* / Q000235:genetics / Q000276:immunology; D013997:Time Factors
chemical_list: D001057:Apolipoproteins E; D016166:Free Radical Scavengers; D000077553:Edaravone; D000983:Antipyrine